Page 10 - April 2021
P. 10
Topic area 3 - Effective treatments for deficient serologic vitamin D (<20 ng/
COVID exist and are inexplicably being mL) were more than twice as likely to
withheld by the FDA and CDC. be infected by the SARS-COV-2 virus
•Comprehensive nutritional study (12.5% vs 5.9%) when compared against
- Used vitamin A (100,000 IU/day), participants with a healthy amount of
vitamin C (1,000mg/hour during serologic vitamin D (≥ 55 ng/mL).
waking), vitamin D (50,000 IU/day), and •Ivermectin study - “Viral clearance was
Lugol’s Iodine (25mg). One hundred treatment dose- and duration-dependent.
seven out of 107 patients fully recovered In six randomized trials of moderate or
within seven days of treatment. severe infection, there was a 75% reduction
•Vitamin D study - 191,779 participants in mortality (Relative Risk=0.25 [95%CI
across all “latitudes, races/ethnicities, 0.12-0.52]; p=0.0002); 14/650 (2.1%)
both sexes, and age ranges” deaths on ivermectin; 57/597 (9.5%) deaths
demonstrated that participants with in controls) with favorable clinical recovery
10 myindigosun.com
